ClinicalTrials.gg
RecruitingNCT05025150Updated Nov 28, 2023

Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial

An observational study in Trauma Chest and Pediatric ALL, sponsored by Sutter Health. Recruiting at 1 site in United States. Open to participants aged 0 Years to 21 Years. Per ClinicalTrials.gov, last updated 2023-11-28.

Sponsored by Sutter Health · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2019; still recruiting 7 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,020
Ages
0 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Thoracic Injuries with a site in United States — 3 open to participants now, 3 under way, none of them phase 3. Thoracic Injuries · United States.

Started
2019
with 1 other
Observational
6 of 14
3 open now
Registered
14th of 14
by date
Lead sponsor
1 of 14
Sutter Health

Among the 14 studies in Thoracic Injuries with a site in United States, this one is one of 2 that started in 2019, is one of 6 observational ones, and was the 14th registered.

Thoracic Injuries

72 studies on the registry are indexed under Thoracic Injuries; 17 are open to participants now.

Browse Thoracic Injuries studies →

Open to participants now

3 of the 14 studies in Thoracic Injuries with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Thoracic Injuries studies recruiting now, 5 set no upper age limit and 1 stops at 75 or younger; 3 take children under 18; none take healthy volunteers.

This study: 0 Years to 21 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Thoracic Injuries with a site in United States, or all of them as a file.
02

Study summary

The objective of the proposed study is to investigate the diagnostic accuracy of ED POCUS in pediatric traumatic thoracic injuries including traumatic pneumothorax, hemothorax, lung contusion, rib fractures, and pulmonary edema (from submersion injury). This will be a prospective, multicenter, observational study of children 0-21 years of age presenting to the participating pediatric emergency departments for suspected traumatic thoracic injury. Results of POCUS will be compared to that of chest X-ray, final clinical diagnosis, computed tomography (CT) or magnetic resonance imaging (MRI). Study hypotheses are that POCUS is highly accurate (90-95%) when compared to chest X-ray, and moderately accurate (\~80%) when compared to CT or MRI in diagnosing these conditions.

03

Conditions studied

  • Trauma Chest
  • Pediatric ALL

Keywords

  • Ultrasonography
04

Who can participate

Ages eligible
0 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  • Suspected penetration injury to neck, chest or abdomen
  • Falls >10 feet or more than 3 times of the child's height
  • Suspected spinal cord injury with neurological deficits
  • Pedestrian or cyclist hit or run over by car at >20mph
  • Motor vehicle collision (MVC) at high speed >50mph or with ejection of occupant
  • MVC with death of another occupant or prolonged extrication time or significant intrusion to passenger compartment.
  • Crash or flip of motorized vehicle with separation of rider from vehicle
  • High voltage electrical injury (>220V)
  • Hanging
  • Submersion injury
  • Trauma mechanism with cardiac arrest or hypotension adjusted for age
  • Explosion injury
  • Treating physician discretion on patients otherwise not meeting any of the above criteria

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eligible subjects will be children 0 to 21 years of age presenting to the participating PEDs meeting trauma activation criteria and with suspected thoracic injury.

Exclusion criteria

Exclusion Criteria:

  • Congenital or acquired cardiopulmonary or osteogenic conditions rendering POCUS ineffective, foreign body/ barrier to lung ultrasound of which removal is , subjects under law-enforcement custody, and subjects deemed unsuitable by treating clinicians.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,020 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Accuracy of POCUS as compared to chest X-ray in detecting injuries

    Time frame: 7-10 days

Secondary outcomes

  1. Compare the accuracy of POCUS to cross sectional imaging (CT or MRI).

    Time frame: 7-10 days

  2. Compare the accuracy of POCUS to chest X-ray or final clinical diagnosis (if no other imaging is performed).

    Time frame: 7-10 days

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2019 (actual). Primary completion is estimated for Aug 2025, 71 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2021
First posted
Aug 27, 2021
StartActual
Aug 11, 2019
Primary completionEst.
Aug 8, 2025
CompletionEst.
Dec 8, 2025
Last update
Nov 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05025150
Lead sponsor
Sutter Health
Responsible party
HIU FUNG SAMUEL LAM (Attending physician, Sutter Health) — Principal investigator
First posted
Aug 27, 2021
Start date
Aug 11, 2019
Primary completion
Aug 8, 2025 (estimated)
Completion
Dec 8, 2025 (estimated)
Last update
Nov 28, 2023

Study contacts

Samuel Lam, MD, MPH
Contact
docp2slam@gmail.com
916 887 1130

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion